PODD - Insulet - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PODD is currently covered by 19 analysts with an average price target of $346.57. This is a potential upside of $32.11 (10.21%) from yesterday's end of day stock price of $314.46.

Insulet's activity chart (see below) currently has 292 price targets and 239 ratings on display. The stock rating distribution of PODD is 22.95% HOLD and 77.05% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 87.8% with an average time for these price targets to be met of 153.52 days.

Highest price target for PODD is $355, Lowest price target is $223, average price target is $282.59.

Most recent stock forecast was given by STEVEN LICHTMAN from OPPENHEIMER on 08-May-2025. First documented stock forecast 27-Mar-2014.

Currently out of the existing stock ratings of PODD, 14 are a HOLD (22.95%), 47 are a BUY (77.05%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$324

$13.33 (4.29%)

$335

5 days ago
(08-May-2025)

3/5 (60%)

$13.33 (4.29%)

217

Buy

$310

$-0.67 (-0.22%)

$285

2 months 23 days ago
(20-Feb-2025)

18/19 (94.74%)

$21.71 (7.53%)

82

Buy

$355

$44.33 (14.27%)

$310

2 months 23 days ago
(20-Feb-2025)

16/18 (88.89%)

$66.71 (23.14%)

196

Buy

$322

$11.33 (3.65%)

$305

2 months 23 days ago
(20-Feb-2025)

3/6 (50%)

$33.71 (11.69%)

94

Buy

$324

$13.33 (4.29%)

$264

4 months 11 days ago
(02-Jan-2025)

2/3 (66.67%)

$57.7 (21.67%)

505

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PODD (Insulet) average time for price targets to be met?

On average it took 153.52 days on average for the stock forecasts to be realized with a an average price target met ratio 87.8

Which analyst has the current highest performing score on PODD (Insulet) with a proven track record?

JOSHUA JENNINGS

Which analyst has the most public recommendations on PODD (Insulet)?

Joshua Jennings has 21 price targets and 13 ratings on PODD

Which analyst is the currently most bullish on PODD (Insulet)?

Joanne Wuensch with highest potential upside - $44.33

Which analyst is the currently most reserved on PODD (Insulet)?

Brooks West with lowest potential downside - -$258.67

Insulet in the News

Insulet Stock Soars To A High After Robust Earnings; This Customer Management Name Pops

Insulet stock soared after the company topped first quarter earnings and sales estimates. And a customer management stock hit a new high. Continue Reading View Comments

Why Insulet (PODD) Stock Is Trading Up Today

What Happened? Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) jumped 20.7% in the afternoon session after the company reported strong first quarter 2025 results which significantly beat analysts’ constant currency revenue, EPS, and EBITDA expectations. Its quarterly revenue guidance also outperformed Wall Street’s estimates. The key number was a 30% jump in constant currency...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?